Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rhodiola rosea in Adult ADHD
NCT02737033Phase 4Unknown
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Apr 2016
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Rhodiola with Placebo (2 arms). Primary endpoint: Change in Stop Signal Task at 4 hours. Status: unknown.
02
Drugs
Vitano
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02737033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02737033.